Botulinum toxin use in movement disorders and spasticity

1Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Ever since botulinum toxin was first used as a treatment for strabismus in 1980, it has become instrumental in the treatment of a myriad of conditions with focal muscle overactivity including cosmetic uses to treat wrinkles. Botulinum toxin use in the treatment of movement disorders including dystonia, hemifacial spasm, tremor, and tics is discussed along with some emphasis on the targeted muscles. Treatment of sialorrhea and spasticity is also discussed.

Cite

CITATION STYLE

APA

Frei, K., & Truong, D. (2017). Botulinum toxin use in movement disorders and spasticity. In Movement Disorders Curricula (pp. 375–383). Springer-Verlag Wien. https://doi.org/10.1007/978-3-7091-1628-9_37

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free